UroSens Ltd.
Urine test to detect cancer
This article was originally published in Start Up
Executive Summary
UroSens Ltd. has developed a test that measures the presence of dividing cells in a urine sample, where there should be no dividing cells, and thus is indicative of cancer. The start-up's lead indication is bladder cancer, but it is exploring its use in other cancers, including prostate.